Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thymus vulgaris essential oil is a **volatile oil extracted from the aerial parts of the Thymus vulgaris plant (common thyme)**. Its main constituents are thymol (typically 23–60%), γ-terpinene, p-cymene, linalool, carvacrol, and other monoterpenes, though composition varies by chemotype and growing conditions[2][6][8]. The primary biological activities stem from thymol and carvacrol, which confer potent **antimicrobial (antibacterial, antifungal, antiviral), antioxidant, anti-inflammatory, antispasmodic, expectorant, and analgesic** properties[1][2][5][6]. Thymus vulgaris essential oil has been traditionally and experimentally used for respiratory tract infections, oral health, skin infections, digestion, muscle pain, and as an insecticidal and preservative agent[1][3][7]. Some studies indicate activity on α1-, α2-, and β-adrenergic receptors due to thymol, with implications for smooth muscle and nerve cell modulation[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thymus vulgaris essential oil.